MDxHealth (MDXH) Enterprise Value (2020 - 2026)

MDxHealth has disclosed Enterprise Value across 7 years of filings, most recently posting -$43.2 million for Q1 2026.

• Enterprise Value for Q1 2026 came in at -$43.2 million, up 34.29% year-over-year; the trailing twelve-month figure through Mar 2026 was -$43.2 million (up 34.29% YoY), and the FY2025 annual result was -$46.8 million, down 109.11% from the prior year.
• Enterprise Value came in at -$43.2 million for Q1 2026 at MDxHealth, down from -$29.0 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of $22.5 million in Q4 2022 to a low of -$262.0 billion in Q2 2025.
• The 5-year median for Enterprise Value is -$39.5 million (2023), against an average of -$15.4 billion.
• Across the five-year window, Enterprise Value jumped 146.66% in 2022 and plunged 1227223.84% in 2025, its largest moves.
• MDxHealth's Enterprise Value stood at $22.5 million in 2022, then declined by 25.51% to $16.8 million in 2023, then tumbled by 379.19% to -$46.8 million in 2024, then surged by 37.96% to -$29.0 million in 2025, then tumbled by 48.64% to -$43.2 million in 2026.
• The last three Enterprise Value figures came in at -$43.2 million (Q1 2026), -$29.0 million (Q4 2025), and -$46.8 million (Q3 2025), per Business Quant data.